This article was published on March 16, 2021, at NEJM.org.DOI: 10.1056/NEJMoa2102214 This clinical trial led by the South African Medical Research Council found that the AstraZeneca jab was ineffective at preventing mild-to-moderate infections with the B1351 variant first found in South Africa